The commercialization of genomic research in Canada

Healthcare Policy

Volumn 6, Issue 2, 2010, Pages 24-32

  Joly, Yann ^a   Caulfield, Timothy ^b,c   Knoppers, Bartha M ^a,d,e   Harmsen, E E F ^e   Pastinen, Tomi ^d,e  

^a MCGILL UNIVERSITY   (Canada)

^b Faculty of Law   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Faculty of Medicine   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; FINANCIAL MANAGEMENT; GENE EXPRESSION; GENETICS; GENOMICS; HEALTH CARE POLICY; HUMAN; MANAGEMENT; ORGANIZATION; PATENT; PROFESSIONAL SECRECY; REVIEW; UNIVERSITY;

EID: 79851487725     PISSN: None     EISSN: 17156572     Source Type: Journal    
DOI: 10.12927/hcpol.2013.22032     Document Type: Review

References (20)

1. Behrens, T.R. and D.O. Gray. 2001. "Unintended Consequences of Cooperative Research: Impact of Industry Sponsorship on Climate for Academic Freedom and Other Graduate Student Outcome." Research Policy 30(2): 179-99. (Pubitemid 33678407)
2. Bekelman, J.E., Y. Li and C.P. Gross. 2003. "Scope and Impact of Financial Conflicts of Interests in Biomedical Research: A Systemic Review." Journal of the American Medical Association 289(4): 454-65. (Pubitemid 36119966)
3. Bennett, A.B., W.D. Steitz and R.A. Gacel. 2007. "Specific Issues with Material Transfer Agreements." In A. Krattiger, R.T. Mahoney and L. Nelsen, eds., Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (p. 698). Oxford, UK: MIHR/PIPRA. Retrieved October 9, 2010. 〈http://www.iphandbook.org/handbook/ch07/p03/ 〉.
4. Blumenthal, D. 2003. "Academic-Industrial Relationships in the Life Sciences." New England Journal of Medicine 349(25): 2452-59. (Pubitemid 37542996)
5. Blumenthal, D., E.G. Campbell, M. Gokhale, R. Yucel, B. Clarridge, S. Hilgartner and N.A. Holtzman. 2006. "Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors." Academic Medicine 81(2): 137-45. (Pubitemid 44356691)
6. Campbell, E.G., B.R. Clarridge, M. Gokhale, L. Birenbaum, S. Hilgartner, N.A. Holtzman and D. Blumenthal. 2002. "Data Withholding in Academic Genetics." Journal of the American Medical Association 287: 473-80.
7. Canadian Biotechnology Advisory Committee. 2005. Human Genetic Materials: Making Canada's Intellectual Property Regime Work for the Health of Canadians. Ottawa: Author.
8. Caulfield, T., T.M. Bubela and C.J. Murdoch. 2007. "Myriad and the Mass Media: The Covering of a Gene Patent Controversy." Genetics in Medicine 9(12): 850-55. (Pubitemid 350295213)
9. Gault, F. and S. McDaniel. 2005. Summary Joint Statistics Canada - University of Windsor Workshop on Intellectual Property Commercialization Indicators. Working Paper (p. 9). Ottawa: Statistics Canada. Retrieved October 9, 2010. 〈http://dsp-psd.tpsgc.gc.ca/Collection/Statcan/88F0006X/ 88F0006XIE2005006.pdf〉.
10. Herder, M. and E.R. Gold. 2007. Intellectual Property Issues in Biotechnology: Health and Industry (pp. 5-8). Paris: Organisation for Economic Co-operation and Development.
11. Hong, W. and J.P. Walsh. 2009. "For Money or Glory? Commercialization, Competition, and Secrecy in the Entrepreneurial University." Sociological Quarterly 50(1): 145-71.
12. Joly, Y., F. Wahnon and B.M. Knoppers. 2007. "Impact of Commercialization of Biotechnology Research on the Communication of Research Results." Harvard Health Policy Review 8(1): 71-84.
13. Joly, Y. 2009. "Patents on Genetic Research Tools: Recent Trends and Future Outlook." In B.M. Knoppers and E.R. Gold, eds., Biotechnology, Ethics and Intellectual Property (pp. 39-57). Markham, ON: LexisNexis Canada.
14. Mills, A.E. and P.M. Tereskerz. 2007. "Changing Patent Strategies: What Will They Mean for the Industry?" Nature Biotechnology 25: 867-68.
15. Murdoch, C.J. and T. Caulfield. 2009. "Commercialization, Patenting and Genomics: Researcher Perspectives." Genome Medicine 1(2): 22. Retrieved October 9, 2010. 〈http://genomemedicine.com/content/1/2/22〉.
16. Organization for Economic Co-operation and Development (OECD). 2006. Guidelines for the Licensing of Genetic Inventions. Paris: Author.
17. Panel on Research Ethics. 2010 (March 22). "Chapter 7: Conflict of Interest." Draft 2nd Edition of the TCPS (December 2008). Retrieved October 9, 2010. 〈http://www.pre.ethics.gc.ca/eng/policypolitique/initiatives/ draft-preliminaire/chapter7-chapitre7/〉.
18. Silverstein, T., Y. Joly, E. Harmsen and B.M. Knoppers. 2009. "The Commercialization of Genomic Academic Research: Conflicting Interests." In B.M. Knoppers and E.R. Gold, eds., Biotechnology, Ethics and Intellectual Property (pp. 131-163). Markham, ON: LexisNexis Canada.
19. Walsh, J.P., A. Arora and W.M. Cohen. 2003. "Research Tool Patenting and Licensing and Biomedical Innovation." In W.M. Cohen and S.A. Merrill, eds., Patents in the Knowledge-Based Economy (p. 285). Washington, DC: National Academies Press.
20. Williams-Jones, B. and C. MacDonald. 2008. "Conflict of Interest Policies at Canadian Universities: Clarity and Content." Journal of Academic Ethics 6(1): 79-90.